HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2006.075614v1 53/1/34    most recent Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Wang, Y. Articles by Xu, A. Search for Related Content PubMed PubMed Citation Articles by Wang, Y. Articles by Xu, A. Related Collections Proteomics and Protein Markers

Lipocalin-2 Is an Inflammatory Marker Closely Associated with Obesity, Insulin Resistance, and Hyperglycemia in Humans

¹ Genome Research Center and Department of Biochemistry, ² Research Center of Heart, Brain, Hormone and Healthy Aging, and ³ Department of Medicine, University of Hong Kong, Hong Kong, China.
⁴ Garvan Institute of Medical Research, University of New South Wales, Darlinghurst, NSW, Australia.
⁵ Department of Biology, York University, Toronto, ONT, Canada.

^aAddress correspondence to this author at: L8-43, Department of Medicine, University of Hong Kong, 21 Sassoon Rd., Hong Kong, China. Fax 852-28162095; e-mail amxu{at}hkucc.hku.hk.

Background: Lipocalin-2, a 25-kDa secreted glycoprotein, is a useful biomarker for early detection of various renal injuries. Because lipocalin-2 is abundantly expressed in adipose tissue and liver, we investigated its relevance to obesity-related pathologies.

Methods: We used real-time PCR and in-house immunoassays to quantify the mRNA and serum concentrations of lipocalin-2 in C57BL/KsJ db/db obese mice and their age- and sex-matched lean littermates. We analyzed the association between serum lipocalin-2 concentrations and various metabolic and inflammatory variables in 229 persons (121 men and 108 women) recruited from a previous cross-sectional study, and we evaluated the effect of the insulin-sensitizing drug rosiglitazone on serum lipocalin-2 concentrations in 32 diabetic patients (21 men and 11 women).

Results: Compared with the lean littermates, lipocalin-2 mRNA expression in adipose tissue and liver and its circulating concentrations were significantly increased in db/db diabetic/obese mice (P <0.001). These changes were normalized after rosiglitazone treatment. In humans, circulating lipocalin-2 concentrations were positively correlated (P <0.005) with adiposity, hypertriglyceridemia, hyperglycemia, and the insulin resistance index, but negatively correlated (P = 0.002) with HDL cholesterol. There was also a strong positive association between lipocalin-2 concentrations and high sensitivity C-reactive protein (hs-CRP), independent of age, sex, and adiposity (P = 0.007). Furthermore, rosiglitazone-mediated decreases in lipocalin-2 concentrations correlated significantly with increases in insulin sensitivity (r = 0.527; P = 0.002) and decreases in hs-CRP concentrations (r = 0.509; P = 0.003).

Conclusions: Lipocalin-2 is an inflammatory marker closely related to obesity and its metabolic complications. Measurement of serum lipocalin-2 might be useful for evaluating the outcomes of various clinical interventions for obesity-related metabolic and cardiovascular diseases.

The following articles in journals at HighWire Press have cited this article:

				A. Cabre, I. Lazaro, J. Girona, J. M. Manzanares, F. Marimon, N. Plana, M. Heras, and L. Masana Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes J. Lipid Res., August 1, 2008; 49(8): 1746 - 1751. [Abstract] [Full Text] [PDF]

				C. Kanaka-Gantenbein, A. Margeli, P. Pervanidou, S. Sakka, G. Mastorakos, G. P. Chrousos, and I. Papassotiriou Retinol-Binding Protein 4 and Lipocalin-2 in Childhood and Adolescent Obesity: When Children Are Not Just "Small Adults" Clin. Chem., July 1, 2008; 54(7): 1176 - 1182. [Abstract] [Full Text] [PDF]

				J. Zhang, Y. Wu, Y. Zhang, D. LeRoith, D. A. Bernlohr, and X. Chen The Role of Lipocalin 2 in the Regulation of Inflammation in Adipocytes and Macrophages Mol. Endocrinol., June 1, 2008; 22(6): 1416 - 1426. [Abstract] [Full Text] [PDF]

				M. T. Flowers, M. P. Keller, Y. Choi, H. Lan, C. Kendziorski, J. M. Ntambi, and A. D. Attie Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet Physiol Genomics, May 9, 2008; 33(3): 361 - 372. [Abstract] [Full Text] [PDF]

				K M Choi, J S Lee, E J Kim, S H Baik, H S Seo, D S Choi, D J Oh, and C G Park Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease Eur. J. Endocrinol., February 1, 2008; 158(2): 203 - 207. [Abstract] [Full Text] [PDF]

				A. Cabre, I. Lazaro, J. Girona, J. M. Manzanares, F. Marimon, N. Plana, M. Heras, and L. Masana Plasma Fatty Acid-Binding Protein 4 Increases with Renal Dysfunction in Type 2 Diabetic Patients without Microalbuminuria Clin. Chem., January 1, 2008; 54(1): 181 - 187. [Abstract] [Full Text] [PDF]

				Q.-W. Yan, Q. Yang, N. Mody, T. E. Graham, C.-H. Hsu, Z. Xu, N. E. Houstis, B. B. Kahn, and E. D. Rosen The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance Diabetes, October 1, 2007; 56(10): 2533 - 2540. [Abstract] [Full Text] [PDF]

				R. M. van Dam and F. B. Hu Lipocalins and Insulin Resistance: Etiological Role of Retinol-Binding Protein 4 and Lipocalin-2? Clin. Chem., January 1, 2007; 53(1): 5 - 7. [Full Text] [PDF]